Pipeline Therapeutics Announces a $1 Billion USD Global Licensing Deal with Janssen Pharma (J&J)
Pipeline Therapeutics and Janssen enter into a global licensing deal for PIPE-307. The deal is valued up to $1B USD.
top of page
Search
Admin
Apr 15, 20236 min read
Six synthetic biology companies that have made a mark
Portfolio Company, Ribbon Biolabs featured as one of the top 6 companies making a mark in Synthetic Biology
Admin
Feb 27, 20232 min read
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership
The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech.
bottom of page